Medunik USA Says Pheburane Remains Available to UCD Patients
Medunik USA reaffirmed its commitment to patients with urea cycle disorders, citing continued availability of Pheburane (sodium phenylbutyrate).
Related stories
Alphabet Shares Fall as Search Advertising Revenue Growth Slows
Alphabet's search advertising revenue grew more slowly in the third quarter, contributing to a drop in its shares. The report says investor patience with big tech's AI spending is
M impact | EQUITY | Oct 29, 2026, 03:19 PM UTC
Perella Weinberg Partners Reports Q3 Revenue of $251.4 Million, Up 52.7%
Perella Weinberg Partners reported third-quarter 2026 revenue of $251.4 million, a 52.7% year-over-year increase. Its shares rose 12.4% in morning trading.
M impact | EQUITY | Oct 29, 2026, 03:18 PM UTC
Stocks in Nigeria Hit All-time High
NSE All Share increased to an all-time high of 254241.00 Index Points. Over the past 4 weeks, Nigerian Stock Exchange All Share Index gained 0.4%, and in the last 12 months, it inc
L impact | EQUITY | Oct 29, 2026, 03:18 PM UTC
Sprouts Shares Fall 19.3% After Results and Comparable-Sales Outlook
Sprouts Farmers Market shares fell 19.3% in the morning session after reporting third-quarter 2026 results and projecting a contraction in full-year comparable-store sales.
M impact | EQUITY | Oct 29, 2026, 03:18 PM UTC
Shell CEO Says Shareholder Payouts Will Not Structurally Fall to 30% of CFFO
Shell’s CEO said the company will not allow shareholder payouts to structurally fall to 30% of cash flow from operations.
L impact | EQUITY | Oct 29, 2026, 03:17 PM UTC
Fiverr Shares Rise 6.3% After Q3 Results and Higher Guidance
Fiverr shares rose 6.3% in morning trading after the company reported third-quarter 2026 results and raised its full-year 2026 guidance ranges.
M impact | EQUITY | Oct 29, 2026, 03:17 PM UTC